About

Medable provides a digital platform that simplifies the process of conducting clinical trials in the healthcare sector. Its main features include tools for onboarding participants, collecting data, sending study notifications, and offering real-time reporting. This platform digitizes the entire clinical trial process, making it easier for pharmaceutical companies and other organizations to gather high-quality data needed to validate their drugs or treatments. Medable stands out from its competitors with its user-friendly design, scalability, and a strong decentralized clinical trial (DCT) network, which allows trials to be conducted remotely. The company aims to support the growing DCT market, which is projected to exceed $12 billion by 2030, by providing a platform that is accessible in over 60 countries and 120 languages.

Simplify's Take

What believers are saying

• Winning the 2024 Prix Galien UK Award for Best Digital Health Solution underscores Medable's industry leadership and innovation.
• Strategic partnerships with organizations like Duke BASE Lab and Pluto Health enhance patient engagement and streamline clinical trial processes.
• Medable's successful adoption of eConsent among elderly patients demonstrates its platform's flexibility and user-friendliness, even for less tech-savvy demographics.

What critics are saying

• The competitive landscape in digital health solutions for clinical trials is intense, requiring continuous innovation to maintain market position.
• Integration of wearable devices and other technologies may face regulatory hurdles, potentially delaying product rollouts.

What makes Medable unique

• Medable's platform is cloud-agnostic and uses a single API, allowing for maximum reach and scalability, unlike competitors tied to specific cloud providers.
• The company's extensive decentralized clinical trial (DCT) network and user-friendly design set it apart in the rapidly growing DCT market.
• Medable's partnerships with leading medical device companies like Masimo enhance its data collection capabilities, providing a more comprehensive dataset for clinical trials.

Help us improve and share your feedback! Did you find this helpful?

YesNo